108 related articles for article (PubMed ID: 7512730)
1. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm I; Kikuchi T; Cardinale I; Krueger JG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3329-33. PubMed ID: 7512730
[TBL] [Abstract][Full Text] [Related]
2. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Tamm I; Cardinale I; Murphy JS
Proc Natl Acad Sci U S A; 1991 May; 88(10):4414-8. PubMed ID: 1852008
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.
Tamm I; Cardinale I; Kikuchi T; Krueger JG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4338-42. PubMed ID: 8183909
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells.
Tamm I; Cardinale I; Sehgal PB
Cytokine; 1991 May; 3(3):212-23. PubMed ID: 1653054
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 enhances motility of breast carcinoma cells.
Sehgal PB; Tamm I
EXS; 1991; 59():178-93. PubMed ID: 1655518
[TBL] [Abstract][Full Text] [Related]
7. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
[TBL] [Abstract][Full Text] [Related]
8. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.
Schleimer RP; Rutledge BK
J Immunol; 1986 Jan; 136(2):649-54. PubMed ID: 2416819
[TBL] [Abstract][Full Text] [Related]
9. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
Chen L; Shulman LM; Revel M
J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
[TBL] [Abstract][Full Text] [Related]
10. alpha 1-Antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells.
Finlay TH; Tamir S; Kadner SS; Cruz MR; Yavelow J; Levitz M
Endocrinology; 1993 Sep; 133(3):996-1002. PubMed ID: 8365378
[TBL] [Abstract][Full Text] [Related]
11. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.
Verhasselt B; Van Damme J; van Larebeke N; Put W; Bracke M; De Potter C; Mareel M
Eur J Cell Biol; 1992 Dec; 59(2):449-57. PubMed ID: 1493810
[TBL] [Abstract][Full Text] [Related]
13. Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1beta and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function.
Hughes R; Timmermans P; Schrey MP
Int J Cancer; 1996 Sep; 67(5):684-9. PubMed ID: 8782659
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester induces morphological changes and acidic fibroblast growth factor RNA expression in the RD/TE 671 cell line.
Hooper WC; Zaki SR; Pruckler J; Garcia J; Evatt BL
Pathobiology; 1990; 58(4):198-203. PubMed ID: 1701302
[TBL] [Abstract][Full Text] [Related]
15. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
16. Human interferon-gamma increases adhesion of cultured carcinoma cells to the substratum.
Marth C; Daxenbichler G; Mayer I; Gastl G; Huber G; Dapunt O
Cancer Lett; 1987 Oct; 37(1):59-69. PubMed ID: 3117353
[TBL] [Abstract][Full Text] [Related]
17. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
18. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.
Kosmas C; Epenetos AA; Courtenay-Luck NS
Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296
[TBL] [Abstract][Full Text] [Related]
19. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
Kudoh M; Knee DA; Takayama S; Reed JC
Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
